Sanaz Nargesi

Dr. Sanaz Nargesi

Mazandaran University of Medical Sciences, Sārī, Māzandarān, Iran
orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 October 2021 in Pathogens
Verified
Journal Article
Open access
PDF file
SNSanaz Nargesi
Sanaz Nargesi
MAMahdi Abastabar
Mahdi Abastabar
RVReza Valadan
Reza Valadan
Sabah MayahiSabah Mayahi
Sabah Mayahi
JYJung-Ho Youn
Jung-Ho Youn
SSSeyedmojtaba Seyedmousavi
Seyedmojtaba Seyedmousavi
Aspergillus flavus is one of the most important agents of invasive and non-invasive aspergillosis, especially in tropical and subtropical regions of the world, including Iran. Aspergillus oryzae is closely related to A. flavus, and it is known for its economic importance in traditional fermentation industries. Reports of infection due to A. oryzae are scarce. Several studies reported that differentiating these two species in clinical laboratories is not possible using MALDI-TOF or by targeting fungal barcode genes, such as Internal Transcribed Spacer (ITS) and β-tubulin (benA). The species-level identification of causative agents and the determination of antifungal susceptibility patterns can play significant roles in the outcome of aspergillosis. Here, we aimed to investigate the discriminatory potential of cyp51A PCR-sequencing versus that of the ITS, benA and calmodulin (CaM) genes for the differentiation of A. flavus from A. oryzae. In a prospective study investigating the molecular epidemiology of A. flavus in Iran between 2008 and 2018, out of 200 clinical isolates of A. flavus, 10 isolates showed >99% similarity to both A. flavus and A. oryzae. Overall, the ITS, β-tubulin and CaM genes did not fulfil the criteria for differentiating these 10 isolates. However, the cyp51A gene showed promising results, which warrants further studies using a larger set of isolates from more diverse epidemiological regions of the world.

30 March 2021 in Journal of Fungi
Verified
Journal Article
Open access
PDF file
SNSanaz Nargesi
Sanaz Nargesi
SKSaeed Kaboli
Saeed Kaboli
JTJose Thekkiniath
Jose Thekkiniath
SSSomaye Heidari sharafdarkolee
Somaye Heidari sharafdarkolee
FKFatemeh Keramati
Fatemeh Keramati
MHMohammad T. Hedayati
Mohammad T. Hedayati
Manipulating fungal genomes is an important tool to understand the function of target genes, pathobiology of fungal infections, virulence potential, and pathogenicity of medically important fungi, and to develop novel diagnostics and therapeutic targets. Here, we provide an overview of recent advances in genetic manipulation techniques used in the field of medical mycology. Fungi use several strategies to cope with stress and adapt themselves against environmental effectors. For instance, mutations in the 14 alpha-demethylase gene may result in azole resistance in Aspergillusfumigatus strains and shield them against fungicide’s effects. Over the past few decades, several genome editing methods have been introduced for genetic manipulations in pathogenic fungi. Application of restriction enzymes to target and cut a double-stranded DNA in a pre-defined sequence was the first technique used for cloning in Aspergillus and Candida. Genome editing technologies, including zinc-finger nucleases (ZFNs) and transcriptional activator-like effector nucleases (TALENs), have been also used to engineer a double-stranded DNA molecule. As a result, TALENs were considered more practical to identify single nucleotide polymorphisms. Recently, Class 2 type II Clustered Regularly Interspaced Short Palindromic Repeat (CRISPR)/Cas9 technology has emerged as a more useful tool for genome manipulation in fungal research.

17 October 2022 in Journal of Fungi
Verified
Journal Article
Open access
PDF file
SNSanaz Nargesi
Sanaz Nargesi
RVReza Valadan
Reza Valadan
MAMahdi Abastabar
Mahdi Abastabar
SKSaeed Kaboli
Saeed Kaboli
JTJose Thekkiniath
Jose Thekkiniath
MHMohammad T. Hedayati
Mohammad T. Hedayati
The antifungal resistance in non-fumigatus Aspergillus spp., as well as Aspergillus fumigatus, poses a major therapeutic challenge which affects the entire healthcare community. Mutation occurrence of cyp51 gene paralogs is the major cause of azole resistance in Aspergillus spp. To obtain a full map of genomic changes, an accurate scan of the entire length of the Aspergillus genome is necessary. In this study, using whole genome sequencing (WGS) technique, we evaluated the mutation in cyp51A, cyp51B, Cdr1B, AtrR, Hmg1, HapE and FfmA genes in different clinical isolates of Aspergillus fumigatus, Aspergillus niger, Aspergillus tubingensis, Aspergillus welwitschiae and Aspergillus terreus which responded to minimum inhibitory concentrations of itraconazole above 16 µg mL−1. We found different nonsynonymous mutations in the cyp51A, cyp51B, Cdr1B, AtrR, Hmg1, HapE and FfmA gene loci. According to our findings, Aspergillus species isolated from different parts of the world may represent different pattern of resistance mechanisms which may be revealed by WGS.

14 November 2023
Verified
Preprint
Open access
PDF file
SNSanaz Nargesi
Sanaz Nargesi
This manuscript holds promising prospects for patients utilizing precision medicine. In the section referring to application of precision medicine in respiratory diseases, it may be better to mention the cystic fibrosis disease as well. This is due...

8 February 2024
Verified
Preprint
Open access
PDF file
SNSanaz Nargesi
Sanaz Nargesi
Dear author; The document is appropriately structured, with sections clearly demarcated and information presented in a coherent manner. The language and writing style are lucid and professional. Although the document offers a comprehensive overview...